| Feature | Specification |
|---|---|
| Unit Size | 1 vial (10 doses) |
| Specificity | αVβ3 Integrin receptor |
IVISense Integrin Receptor 680 fluorescent imaging probe for in vivo detection of αvβ3 integrin is a low molecular weight peptidomimetic antagonist coupled to a red fluorochrome. This validated, high affinity (Kd = 4.2 nM) fluorescent probe has improved circulation half-life and specificity over RDG peptide-based agents, with selectivity 5-20x for αvβ3 integrin, for precise detection of αvβ3 integrins. This integrin-targeted molecular imaging agent enables non-invasive imaging to better understand biological processes, and disease biology and progression.
Including IVISense Integrin Receptor 680 fluorescent agent in careful experimental design allows for multiplexing with other channels and/or imaging times, and can be paired with other probes to achieve maximum efficiency and flexibility in your imaging studies.
| Brand |
IVISense
|
|---|---|
| Fluorescent Agent Type |
Targeted
|
| Imaging Modality |
Fluorescence
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Specificity |
αVβ3 Integrin receptor
|
| Storage Conditions |
-30 to -16 °C
|
| Therapeutic Area |
Angiogenesis
Atherosclerosis
Cardiovascular
Inflammation
Oncology
Pulmonary
Vascular
|
| Unit Size |
1 vial (10 doses)
|
| Wave Length |
680 nm
|
Are you looking for resources, click on the resource type to explore further.
In vivo fluorescence imaging displays a very broad utility and has become a well-established modality for functional imaging in...
We are here to answer your questions.